Literature DB >> 35125690

Analysis of the Pattern, Alliance and Risk of rs1799752 (ACE I/D Polymorphism) with Essential Hypertension.

Digishaben D Patel1, Deepak N Parchwani2, Nirupama Dikshit3, Tanishk Parchwani4.   

Abstract

Studies in spontaneously hypertensive rat had revealed an elevated level of ACE gene expression in the tissues and is substantiated by experimental clinical studies for a positive correlation between ACE I/D polymorphism and hypertension. Aim: To determine whether the polymorphic variant of ACE gene in intron 16 confers susceptibility to essential hypertension. I/D polymorphism at the locus intron 16 of the ACE gene were amplified from the genomic DNA of the total 571 (hypertensive patients, n: 279; controls, n: 292) participants using polymerase chain reaction and gel electrophoresis methods and were examined in a case-control approach. Suitable descriptive statistics was used for different variables. Result revealed significant heterogeneity under the allele (p: 0.0002) and genotype (p: 0.0001) contrast in hypertensive patients than in normal controls, with an increased frequency of D allele (62.72%; p < 0.0001; OR: 1.8144; 95% CI: 1.4327-2.2979) and DD genotype (41.93%; p: < 0.0001). A significant association was found in the DD variant with disease phenotype (p: 0.0018, 95% CI: 1.3303-3.4907; OR: 2.1549; Table 31) and is substantiated by the data of multivariate analysis, demonstrating a statistically significant increase in odds of hypertension with the ACE D/D genotype (OR: 2.09; 95% CI: 1.24-2.91). Conspicuously, subgroup analysis by gender did not change this pattern of results. Albeit the allele distribution resulted in a higher frequency of the D/D genotype in the cases than controls, testing genetic equilibrium between the observed and expected genotypes using Hardy-Weinberg equilibrium showed ACE gene variants were confirming to the law in hypertensive as well as in non-hypertensive participants. I/D polymorphism in the angiotensin-I-converting enzyme gene at the 16th intron can be useful for outcome predictions during diagnostic processes can be implicated in an individual's propensity for hypertension and thus implies that genetic variants of ACE I/D might serve as a predictor for the susceptibility to hypertension. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  Angiotensin converting enzyme; Hypertension; Polymerase chain reaction; Polymorphism

Year:  2020        PMID: 35125690      PMCID: PMC8799835          DOI: 10.1007/s12291-020-00927-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  43 in total

Review 1.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

2.  Angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in the Chinese population: a meta-analysis including 21,058 participants.

Authors:  Y Li
Journal:  Intern Med J       Date:  2012-04       Impact factor: 2.048

Review 3.  Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes.

Authors:  J A Staessen; G Ginocchio; J G Wang; A P Saavedra; F Soubrier; R Vlietinck; R Fagard
Journal:  J Cardiovasc Risk       Date:  1997 Oct-Dec

4.  Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men : the Suita Study.

Authors:  J Higaki; S Baba; T Katsuya; N Sato; K Ishikawa; T Mannami; J Ogata; T Ogihara
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

5.  A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals.

Authors:  Jasper J Brugts; Aaron Isaacs; Moniek Pm de Maat; Eric Boersma; Cock M van Duijn; K Martijn Akkerhuis; Andre G Uitterlinden; Jacqueline Cm Witteman; Francois Cambien; Claudio Ceconi; Willem Remme; Michel Bertrand; Toshiharu Ninomiya; Stephen Harrap; John Chalmers; Stephen Macmahon; Kim Fox; Roberto Ferrari; Maarten L Simoons; Ah Jan Danser
Journal:  J Hypertens       Date:  2011-03       Impact factor: 4.844

6.  Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension.

Authors:  N Tascilar; A Dursun; H Ankarali; G Mungan; S Ekem; S Baris
Journal:  J Neurol Sci       Date:  2009-10-15       Impact factor: 3.181

7.  Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis.

Authors:  Lin-dan Ji; Li-na Zhang; Peng Shen; Ping Wang; Yue-miao Zhang; Wen-hua Xing; Jin Xu
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies.

Authors:  Santiago Rodriguez; Tom R Gaunt; Ian N M Day
Journal:  Am J Epidemiol       Date:  2009-01-06       Impact factor: 4.897

10.  Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease.

Authors:  R Shanmuganathan; R Kumaresan; P Giri
Journal:  J Postgrad Med       Date:  2015 Oct-Dec       Impact factor: 1.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.